These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36563525)
1. Enzymatic biofuel cell-powered iontophoretic facial mask for enhanced transdermal drug delivery. Li Z; Wu R; Chen K; Gu W; Zhang YP; Zhu Z Biosens Bioelectron; 2023 Mar; 223():115019. PubMed ID: 36563525 [TBL] [Abstract][Full Text] [Related]
2. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress. Wang Y; Zeng L; Song W; Liu J Drug Deliv Transl Res; 2022 Jan; 12(1):15-26. PubMed ID: 33486687 [TBL] [Abstract][Full Text] [Related]
3. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle. Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718 [TBL] [Abstract][Full Text] [Related]
4. Transdermal iontophoretic drug delivery: advances and challenges. Ita K J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291 [TBL] [Abstract][Full Text] [Related]
5. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers. Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965 [TBL] [Abstract][Full Text] [Related]
6. To enhance the efficiency of nefopam transdermal iontophoresis by using a novel method based on ion-exchange fiber. Xin C; Lihong W; Fei H; Yan W; Qifang W; Yang Y; Yue Y; San-ming L Drug Dev Ind Pharm; 2014 Jan; 40(1):9-16. PubMed ID: 23317337 [TBL] [Abstract][Full Text] [Related]
7. Iontophoretic transdermal delivery of glycyrrhizin: effects of pH, drug concentration, co-ions, current intensity, and chemical enhancers. Yamamoto R; Takasuga S; Kominami K; Sutoh C; Kinoshita M; Kanamura K; Takayama K Chem Pharm Bull (Tokyo); 2013; 61(12):1275-81. PubMed ID: 24292789 [TBL] [Abstract][Full Text] [Related]
14. Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis. Park J; Lee H; Lim GS; Kim N; Kim D; Kim YC AAPS PharmSciTech; 2019 Jan; 20(3):96. PubMed ID: 30694397 [TBL] [Abstract][Full Text] [Related]
15. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate. Kolli CS; Xiao J; Parsons DL; Babu RJ Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925 [TBL] [Abstract][Full Text] [Related]
17. Iontophoresis for the cutaneous delivery of nanoentraped drugs. Andrade JFM; Cunha-Filho M; Gelfuso GM; Gratieri T Expert Opin Drug Deliv; 2023 Jun; 20(6):785-798. PubMed ID: 37119173 [TBL] [Abstract][Full Text] [Related]
18. Smartphone-based iontophoresis transdermal drug delivery system for cancer treatment. Kim TH; Kim NY; Lee HU; Choi JW; Kang T; Chung BG J Control Release; 2023 Dec; 364():383-392. PubMed ID: 37914000 [TBL] [Abstract][Full Text] [Related]
19. AC electrokinetic platform for iontophoretic transdermal drug delivery. Lvovich VF; Matthews E; Riga AT; Kaza L J Control Release; 2010 Jul; 145(2):134-40. PubMed ID: 20420867 [TBL] [Abstract][Full Text] [Related]
20. Investigation of in vitro iontophoresis facilitated transdermal delivery of glycine. Dasgupta R; Banthia AK; Tibarewala DN Curr Drug Deliv; 2009 Apr; 6(2):145-50. PubMed ID: 19450220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]